|
Challenges in sentinel node (SN) pathology in the era of adjuvant treatment: The risk of over and undertreatment stress the need for expert pathology review. |
|
|
Consulting or Advisory Role - AMGEN (Inst) |
Research Funding - Amgen (Inst) |
Travel, Accommodations, Expenses - AMGEN |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen |
|
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Alexander Christopher Jonathan Van Akkooi |
Consulting or Advisory Role - 4SC (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); MSD Oncology (Inst); Novartis (Inst) |
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst) |
Travel, Accommodations, Expenses - Novartis |